John A Taylor, III, MD, MS is the John W Weigel Professor of Urology & Cancer Biology. He is the director of basic urologic research in the Department of Urology and the co-leader of the Drug Discovery Delivery and Experimental Therapeutics Program at the University of Kansas Cancer Center. A native of New York, he completed his MD at Columbia University’s College of Physicians and Surgeons in New York City, where he stayed to complete his internship and residency in general surgery and urology. He subsequently served for three years on active duty at Walter Reed Army Medical Center, where he was director of medical education for urology and assistant professor at Uniformed Services University of the Health Sciences. After completing his military obligation, he took a faculty position at the University of Connecticut Health Center during which time he completed a master’s degree in clinical and translation science and was promoted to professor.
Dr. Taylor is an avid translational researcher with an active lab that pursues novel drug discovery/therapeutics for bladder cancer. He has enjoyed continued extramural funding inclusive of grants and philanthropic donations since 2005. These have included a Jahnigen Scholars Award from the American Geriatrics Society, an American Geriatrics Society/John A. Hartford Foundation Geriatrics Education for Specialty Residents educational grant, an American Cancer Society Mentored Research Scholar Award and National Institutes of Health R01s as a co-investigator. Most recently, his lab and research have been supported by a Department of Defense Grant and continual philanthropic donation from the Albert Charitable Trust. His work has been recognized by multiple peer-reviewed publications and several U.S. provisional/full patents. In addition, he is engaged in clinical trials exploring new therapeutics for treatment of bladder cancer and is part of the team that brought the first KU invented drug from bench to bedside for the treatment of bladder cancer.